Multiple sclerosis in children

Area of Science:

• Neurology
• Immunology
• Pediatrics

Background:

• Multiple sclerosis (MS) is a primary immune-mediated demyelinating disease, predominantly affecting young adults.
• Pediatric MS, defined as onset before age 16, accounts for 4%-5% of the overall MS population.
• While sharing similarities with adult MS, pediatric MS presents unique epidemiological and clinical considerations.

Purpose of the Study:

• To comprehensively review the epidemiology of pediatric MS.
• To explore the etiology and clinical manifestations of MS in children.
• To summarize current treatment approaches for pediatric MS.

Main Methods:

• Systematic literature review of epidemiological data.
• Analysis of clinical presentation and disease course in pediatric MS patients.
• Review of treatment guidelines and outcomes for children with MS.

Main Results:

• Pediatric MS (onset <16 years) comprises 4%-5% of MS cases.
• Approximately 80% of pediatric and nearly all adolescent-onset MS cases exhibit typical adult MS attack patterns.
• Children with MS experience more frequent and severe relapses compared to adults, with 97%-99% presenting the relapsing-remitting form.

Conclusions:

• Pediatric MS is a significant clinical entity with distinct features, including more aggressive relapses.
• The management of MS in children follows similar therapeutic strategies as in adults.
• Further research into the specific etiology and long-term outcomes of pediatric MS is warranted.